Medical Nutrition Therapy for Chronic Kidney Disease Improves Biomarkers and Slows Time to Dialysis Desirée de Waal, MS, RD, CD, FAND, Emily Heaslip, MS, RD, CD, Peter Callas, PhD Journal of Renal Nutrition Volume 26, Issue 1, Pages 1-9 (January 2016) DOI: 10.1053/j.jrn.2015.08.002 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Progression to dialysis (in days) of patients who received medical nutrition therapy (MNT) compared with those who did not. (A) At all stages of CKD at baseline. (B) Stratified by Stage 3 at baseline. (C) Stratified by Stage 4 at baseline. (D) Stratified by Stage 5. Time 0 is baseline, which is date of CKD diagnosis by a nephrologist and documented in the electronic medical records. Survival probability (Kaplan-Meier survival estimates) means the proportion of patients not on dialysis. (1 indicates that dialysis has not started, 0 indicates that dialysis had started). + Denotes participants who did not start dialysis during the duration of the study and were censored at the date of the most recent laboratory data. Journal of Renal Nutrition 2016 26, 1-9DOI: (10.1053/j.jrn.2015.08.002) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions